DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Brains Matter

June 1, 2020
We SEE You! Nominations Open For EBCI's 2020 National "HOPE AWARD"…

One of my most favorite things to do under my leadership of the EndBrainCancer Initiative is to talk directly to patients with brain cancer and to hear first hand, “their story” and to “see” with my own eyes as well as to “hear” with my own ears how they IMPACT others.

Read More
May 29, 2020
2020 National HOPE Award – A Message From Our President

I am spending my day reflecting on the national brain tumor community.  Specifically, I am also spending a lot of time over the last several weeks, amongst COVID-19, reflecting on the my late husband’s brain cancer journey and the last 18 years of co-founding and running the Chris Elliott Fund, now DBA EndBrainCancer Initiative.

Read More
July 15, 2019
The EndBrainCancer Initiative Calls on All Americans to Recognize and Support the Inaugural National GBM Awareness Day on July 17th

In June, the U.S. Senate took swift action and passed Senate Resolution 245 by unanimous consent. July 17, 2019 is officially “Glioblastoma Awareness Day” nationally (#GBMDay)!

Read More
June 13, 2019
EndBrainCancer Initiative Announced Campaign for New Brain Cancer Clinical Trials in the Greater Puget Sound Area at its Education, Awareness & Action Dinner

The EndBrainCancer Initiative (EBCI) held its 8th Annual “Brains Matter” Dinner on May 15th raising $57,500 for its work. The “Hopeless to HOPE campaign” was announced.

Read More
June 7, 2018
National Press Release: The EndBrainCancer Initiative Champions Changes to Standards of Care at its 7th Annual Brains Matter Dinner

On May 17th the EndBrainCancer Initiative’s 7th annual Brains Matter & Igniting Hope Celebration, Awareness and Fundraising Dinner was held in Bellevue, Washington near Seattle.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram